EVO
Evotec (EVO)
$53
About Evotec (EVO)
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.
Details
Daily high
$2.57
Daily low
$2.52
Price at open
$2.53
52 Week High
$4.80
52 Week Low
$2.31
Market cap
831.7M
Dividend yield
0.00%
Volume
87,278
Avg. volume
134,733
P/E ratio
-4.71
Evotec News
Details
Daily high
$2.57
Daily low
$2.52
Price at open
$2.53
52 Week High
$4.80
52 Week Low
$2.31
Market cap
831.7M
Dividend yield
0.00%
Volume
87,278
Avg. volume
134,733
P/E ratio
-4.71